U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302087) titled 'Platelet Serotonin Deficiencies: the Strasbourg Experience' on Dec. 11.
Brief Summary: Hemorrhagic syndromes are investigated using algorithms established by reference centers and hemostasis societies.
The investigation of platelet dense granules (nucleotide and serotonin testing) is part of the second-line tests.
It can be performed in cases of platelet aggregation abnormalities in platelet-rich plasma (PRP) suggesting a secretion abnormality, or in cases where the latter is normal, it can be performed if the patient's clinical presentation points to a primary hemostasis abnormality and the clinician wishes to pursue further inve...